Nwam LLC Invests $98,000 in Enovix Co. (NASDAQ:ENVX)

Nwam LLC purchased a new stake in Enovix Co. (NASDAQ:ENVXFree Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 10,449 shares of the company’s stock, valued at approximately $98,000.

Other institutional investors have also recently bought and sold shares of the company. Prospera Private Wealth LLC acquired a new position in Enovix during the 3rd quarter valued at about $27,000. Blue Trust Inc. lifted its holdings in Enovix by 102.1% in the second quarter. Blue Trust Inc. now owns 1,894 shares of the company’s stock valued at $29,000 after buying an additional 957 shares during the period. Beacon Capital Management LLC lifted its holdings in Enovix by 71.9% in the first quarter. Beacon Capital Management LLC now owns 4,298 shares of the company’s stock valued at $34,000 after buying an additional 1,798 shares during the period. GAMMA Investing LLC boosted its stake in Enovix by 11,176.2% in the second quarter. GAMMA Investing LLC now owns 2,368 shares of the company’s stock valued at $37,000 after acquiring an additional 2,347 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL bought a new stake in shares of Enovix during the 2nd quarter valued at $39,000. Institutional investors own 50.92% of the company’s stock.

Enovix Stock Down 3.3 %

ENVX stock opened at $9.22 on Wednesday. The business has a 50-day moving average of $10.00 and a 200-day moving average of $11.31. Enovix Co. has a fifty-two week low of $5.70 and a fifty-two week high of $18.68. The stock has a market capitalization of $1.64 billion, a P/E ratio of -5.73 and a beta of 1.99. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61.

Enovix (NASDAQ:ENVXGet Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.03. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. The company had revenue of $4.30 million for the quarter, compared to the consensus estimate of $4.11 million. During the same period last year, the company earned ($0.27) earnings per share. On average, sell-side analysts anticipate that Enovix Co. will post -1.17 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Arthi Chakravarthy sold 35,000 shares of the business’s stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $13.00, for a total value of $455,000.00. Following the completion of the sale, the insider now directly owns 343,305 shares in the company, valued at approximately $4,462,965. The trade was a 9.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 15.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

ENVX has been the topic of several recent research reports. JPMorgan Chase & Co. reduced their price target on Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Janney Montgomery Scott lowered Enovix from a “buy” rating to a “neutral” rating and set a $10.00 target price for the company. in a research report on Thursday, October 31st. TD Cowen boosted their price target on shares of Enovix from $11.00 to $14.00 and gave the company a “hold” rating in a report on Thursday, August 1st. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research note on Wednesday, October 30th. Finally, Benchmark reissued a “buy” rating and issued a $25.00 target price on shares of Enovix in a research note on Wednesday, October 30th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $20.50.

Get Our Latest Report on ENVX

Enovix Company Profile

(Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

See Also

Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVXFree Report).

Institutional Ownership by Quarter for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.